Published Online: March 5, 2015. doi:10.1001/jamaophthalmol.2015.126.
Study concept and design: Litts, Dellatorre, Freund, Curcio.
Acquisition, analysis, or interpretation of data: Litts, Messinger, Yannuzzi, Freund, Curcio.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: Litts, Dellatorre, Yannuzzi, Freund, Curcio.
Obtained funding: Yannuzzi, Freund.
Administrative, technical, or material support: Messinger, Dellatorre, Yannuzzi, Curcio.
Study supervision: Yannuzzi, Freund, Curcio.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Freund reported being a consultant for Heidelberg Engineering, Genentech, Bayer HealthCare, Regeneron, Optos, and Thrombogenics. No other disclosures were reported.
Funding/Support: This work was supported by grant R01EY06109 from the National Institutes of Health and by grants from The Macula Foundation; the Vision Science Graduate Program, University of Alabama at Birmingham; the Eyesight Foundation of Alabama; and Research to Prevent Blindness to the Department of Ophthalmology, University of Alabama at Birmingham.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.